Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a significant decline in short interest during the month of June. As of June 30th, there was short interest totaling 60,839 shares, a decline of 85.1% from the June 15th total of 409,683 shares. Currently, 1.0% of the shares of the stock are short sold. Based on an average daily volume of 251,416 shares, the days-to-cover ratio is currently 0.2 days.

Insider Transactions at Nanovibronix

In related news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $0.69, for a total transaction of $144,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on FEED. Weiss Ratings reissued a “sell (e+)” rating on shares of Nanovibronix in a report on Friday, April 24th. Wall Street Zen raised Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Tuesday, April 28th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Nanovibronix Stock Down 1.6%

Shares of FEED traded down $0.01 on Friday, hitting $0.53. 523,274 shares of the stock traded hands, compared to its average volume of 362,778. Nanovibronix has a 1 year low of $0.42 and a 1 year high of $17.40. The firm has a 50 day moving average price of $0.84. The stock has a market cap of $3.22 million, a price-to-earnings ratio of -0.06 and a beta of 1.56.

Nanovibronix (NASDAQ:FEED) last released its earnings results on Monday, May 18th. The company reported ($6.88) EPS for the quarter. Nanovibronix had a negative return on equity of 54.25% and a negative net margin of 923.20%.The firm had revenue of $0.65 million during the quarter.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.